Herpes Simplex Virus: Molecular Pathogenesis, Type-Specific Disease Burden, and Advances in Prevention and Treatment
Viruses · 2026
DOI: 10.3390/v18101116 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Chenhao Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control, Bei…. Hauptthemen laut MEDLINE: Herpes Simplex, Herpesvirus 1, Human, Simplexvirus, Herpesvirus 2, Human. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Herpes simplex virus (HSV) is a highly prevalent neurotropic DNA virus that causes orolabial herpes, genital herpes, keratitis, neonatal infection, meningitis and encephalitis. HSV-1 and HSV-2 share epithelial entry, lytic replication, immune evasion, lifelong sensory-ganglion latency and periodic reactivation, yet they differ in typical transmission routes, anatomical recurrence and public-health burden. Rather than mechanically separating both viruses throughout, this review emphasizes shared HSV biology and highlights type-specific differences where they affect clinical interpretation or intervention design. We connect glycoprotein-mediated entry, receptor use, axonal transport, immune evasion and latency with mucocutaneous, ocular, neurologic, neonatal and genital disease. We then synthesize lessons from failed glycoprotein-D vaccine trials, multivalent and mRNA platforms, helicase–primase inhibitors, monoclonal antibodies, RNA-based approaches, genome editing and latency-directed strategies. A mechanism-guided HSV strategy should reduce acquisition, shedding and recurrence, prevent ocular, neurologic and neonatal complications, manage antiviral resistance and ultimately address latent infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control, Beijing 102629, China.
- National Vaccine and Serum Institute (NVSI), Beijing 101111, China.
ORCID-Profile: Jianhui Nie, Li Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, C., Nie, J., & Zhang, L. (2026). Herpes Simplex Virus: Molecular Pathogenesis, Type-Specific Disease Burden, and Advances in Prevention and Treatment. Viruses. https://doi.org/10.3390/v18101116
Vancouver
Jiang C, Nie J, Zhang L. Herpes Simplex Virus: Molecular Pathogenesis, Type-Specific Disease Burden, and Advances in Prevention and Treatment. Viruses. 2026. doi:10.3390/v18101116
BibTeX
@article{Jiang2026,
author = {Jiang, Chenhao and Nie, Jianhui and Zhang, Li},
title = {Herpes Simplex Virus: Molecular Pathogenesis, Type-Specific Disease Burden, and Advances in Prevention and Treatment},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18101116}
}
EUVIMED